Intact Transition Epitope Mapping - Targeted High-Energy Rupture of Extracted Epitopes (ITEM-THREE).

Affinity proteomics Antibodies* Assay development BLAST Immunology* Ligand -Receptor Interactions* Mass Spectrometry Non-covalent interaction MS* Protein complex analysis Targeted mass spectrometry Therapeutic antibodies* data base search epitope mapping peptide sequencing

Journal

Molecular & cellular proteomics : MCP
ISSN: 1535-9484
Titre abrégé: Mol Cell Proteomics
Pays: United States
ID NLM: 101125647

Informations de publication

Date de publication:
08 2019
Historique:
received: 04 03 2019
revised: 14 05 2019
pubmed: 31 5 2019
medline: 6 6 2020
entrez: 1 6 2019
Statut: ppublish

Résumé

Epitope mapping, which is the identification of antigenic determinants, is essential for the design of novel antibody-based therapeutics and diagnostic tools. ITEM-THREE is a mass spectrometry-based epitope mapping method that can identify epitopes on antigens upon generating an immune complex in electrospray-compatible solutions by adding an antibody of interest to a mixture of peptides from which at least one holds the antibody's epitope. This mixture is nano-electrosprayed without purification. Identification of the epitope peptide is performed within a mass spectrometer that provides an ion mobility cell sandwiched in-between two collision cells and where this ion manipulation setup is flanked by a quadrupole mass analyzer on one side and a time-of-flight mass analyzer on the other side. In a stepwise fashion, immune-complex ions are separated from unbound peptide ions and dissociated to release epitope peptide ions. Immune complex-released peptide ions are separated from antibody ions and fragmented by collision induced dissociation. Epitope-containing peptide fragment ions are recorded, and mass lists are submitted to unsupervised data base search thereby retrieving both, the amino acid sequence of the epitope peptide and the originating antigen. ITEM-THREE was developed with antiTRIM21 and antiRA33 antibodies for which the epitopes were known, subjecting them to mixtures of synthetic peptides of which one contained the respective epitope. ITEM-THREE was then successfully tested with an enzymatic digest of His-tagged recombinant human β-actin and an antiHis-tag antibody, as well as with an enzymatic digest of recombinant human TNFα and an antiTNFα antibody whose epitope was previously unknown.

Identifiants

pubmed: 31147491
pii: S1535-9476(20)34057-3
doi: 10.1074/mcp.RA119.001429
pmc: PMC6683010
pii:
doi:

Substances chimiques

Actins 0
Antibodies 0
Antigen-Antibody Complex 0
Epitopes 0
Peptides 0
Ribonucleoproteins 0
SS-A antigen 0
TNF protein, human 0
Tumor Necrosis Factor-alpha 0

Banques de données

PDB
['1tnf.pdb']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1543-1555

Informations de copyright

© 2019 Danquah et al.

Références

J Am Soc Mass Spectrom. 1995 Aug;6(8):638-43
pubmed: 24214390
Trends Biochem Sci. 2017 Feb;42(2):155-167
pubmed: 28089412
Methods. 2015 Nov 1;89:30-7
pubmed: 25726909
Int J Cancer. 2019 Jul 1;145(1):232-241
pubmed: 30586191
Anal Chem. 2018 Nov 6;90(21):12796-12801
pubmed: 30299922
Anal Bioanal Chem. 2019 Jan;411(2):439-448
pubmed: 30498982
Methods Mol Biol. 2009;524:119-34
pubmed: 19377941
Anal Chem. 2011 Oct 15;83(20):7657-61
pubmed: 21894996
J Am Soc Mass Spectrom. 2010 Oct;21(10):1699-711
pubmed: 20116281
Rapid Commun Mass Spectrom. 2014 Dec 30;28(24):2729-34
pubmed: 25380495
Nat Med. 2018 Jun;24(6):857-867
pubmed: 29867235
Bioconjug Chem. 1994 Nov-Dec;5(6):583-90
pubmed: 7873661
Anal Bioanal Chem. 2012 Apr;403(1):227-38
pubmed: 22349330
Proteomics. 2003 Aug;3(8):1526-34
pubmed: 12923778
Chem Sci. 2016 Feb 1;7(2):1480-1486
pubmed: 29910905
Angew Chem Int Ed Engl. 2018 Dec 17;57(51):16688-16692
pubmed: 30393918
Anal Bioanal Chem. 2004 Feb;378(4):1102-11
pubmed: 12955276
Proteomics Clin Appl. 2009 Jul;3(7):797-809
pubmed: 21136988
Annu Rev Phys Chem. 2014;65:175-96
pubmed: 24328447
J Mol Recognit. 2014 Sep;27(9):566-74
pubmed: 25042711
J Infect Dis. 2018 May 25;217(12):1907-1917
pubmed: 29528415
Eur J Mass Spectrom (Chichester). 2017 Dec;23(6):445-459
pubmed: 29183193
J Am Soc Mass Spectrom. 2018 Sep;29(9):1881-1891
pubmed: 29943080
Proc Natl Acad Sci U S A. 1990 Dec;87(24):9848-52
pubmed: 1702219
Eur J Mass Spectrom (Chichester). 2009;15(6):747-59
pubmed: 19940341
Adv Exp Med Biol. 2016;919:397-431
pubmed: 27975228
J Biosci. 2016 Dec;41(4):787-803
pubmed: 27966496
J Am Soc Mass Spectrom. 2011 Oct;22(10):1679-89
pubmed: 21952881
Proteomics Clin Appl. 2018 Nov;12(6):e1800017
pubmed: 29956482
Anal Chem. 1998 Jun 1;70(11):2236-42
pubmed: 9624897
Methods Mol Biol. 2018;1785:13-27
pubmed: 29714009
Semin Nucl Med. 2016 Jan;46(1):47-56
pubmed: 26687857
J Am Soc Mass Spectrom. 2003 Oct;14(10):1076-85
pubmed: 14530088
Mass Spectrom Rev. 2018 Mar;37(2):229-241
pubmed: 27403762
J Am Soc Mass Spectrom. 2017 Aug;28(8):1612-1622
pubmed: 28616748
Chem Soc Rev. 2010 May;39(5):1633-55
pubmed: 20419213
J Immunol. 1996 Jul 1;157(1):198-206
pubmed: 8683115
Methods Mol Biol. 2018;1785:29-51
pubmed: 29714010
J Am Soc Mass Spectrom. 2011 Jun;22(6):976-88
pubmed: 21953039
Anal Chem. 2019 Mar 5;91(5):3611-3618
pubmed: 30688442
J Mol Recognit. 2015 Jun;28(6):393-400
pubmed: 25726811
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Biochem Biophys Res Commun. 2004 Jul 30;320(3):846-51
pubmed: 15240125
Annu Rev Biochem. 1990;59:439-73
pubmed: 2197980
Expert Rev Proteomics. 2005 Aug;2(4):553-65
pubmed: 16097888
Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5630-4
pubmed: 1608973
Anal Bioanal Chem. 2017 Nov;409(28):6549-6558
pubmed: 28900708
BioDrugs. 2007;21(3):145-56
pubmed: 17516710
Methods Enzymol. 2017;586:433-452
pubmed: 28137575
Curr Opin Chem Biol. 2018 Feb;42:25-33
pubmed: 29128665
J Mass Spectrom. 2008 Feb;43(2):185-95
pubmed: 17924399
Sci Rep. 2016 Aug 11;6:31365
pubmed: 27509843
J Proteome Res. 2008 Jan;7(1):202-8
pubmed: 18092745
J Am Soc Mass Spectrom. 2016 Sep;27(9):1435-42
pubmed: 27287047
Anal Chem. 2017 Feb 21;89(4):2250-2258
pubmed: 28193005
J Mass Spectrom. 2000 Jan;35(1):1-12
pubmed: 10633229
J Mass Spectrom. 2013 Jun;48(6):651-9
pubmed: 23722955
Biochemistry. 1996 Dec 10;35(49):15633-9
pubmed: 8961925
BioDrugs. 2018 Apr;32(2):99-109
pubmed: 29516371
Anal Chem. 2013 Nov 5;85(21):10479-87
pubmed: 24094071
Angew Chem Int Ed Engl. 2012 Apr 27;51(18):4336-9
pubmed: 22438323
Mol Syst Biol. 2014 Apr 08;10:724
pubmed: 24714364

Auteurs

Bright D Danquah (BD)

‡Proteome Center Rostock, University Medicine Rostock, Rostock, Germany.

Claudia Röwer (C)

‡Proteome Center Rostock, University Medicine Rostock, Rostock, Germany.

KwabenaF M Opuni (KM)

§School of Pharmacy, University of Ghana, Legon, Ghana.

Reham El-Kased (R)

¶Microbiology and Immunology Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt.

David Frommholz (D)

‖University of Applied Sciences Bonn-Rhein-Sieg, Immunology and Cell Biology, Rheinbach, Germany.

Harald Illges (H)

‖University of Applied Sciences Bonn-Rhein-Sieg, Immunology and Cell Biology, Rheinbach, Germany;; **University of Applied Sciences Bonn-Rhein-Sieg, Institute for Functional Gene Analytics, Rheinbach, Germany.

Cornelia Koy (C)

‡Proteome Center Rostock, University Medicine Rostock, Rostock, Germany.

Michael O Glocker (MO)

‡Proteome Center Rostock, University Medicine Rostock, Rostock, Germany. Electronic address: michael.glocker@med.uni-rostock.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH